Metagenics will continue to support and expand the activities of Amipro. Amipro has a strong and well-respected image in the South African market, which is a perfect basis for further growth and development. There will be no changes for the customers. All services and products for the prescribers and patients will remain the same, and the team of Nutritional advisors and customer support will remain fully operational.
Lorraine Leas, founder and CEO of Amipro, and Taryn de Villiers, COO, will support the transition of Amipro into the management of Metagenics as consultants, and help Metagenics to establish a firm relationship with its customers.